Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice

IntroductionNeuropilin 2 (NRP2) mediates the effects of class 3 semaphorins and vascular endothelial growth factor and is implicated in axonal guidance and angiogenesis. Moreover, NRP2 expression is suggested to be involved in the regulation of bone homeostasis. Indeed, osteoblasts and osteoclasts e...

Full description

Bibliographic Details
Main Authors: Lieve Verlinden, Stefanie Doms, Iris Janssens, Mark B. Meyer, J. Wesley Pike, Geert Carmeliet, Annemieke Verstuyf
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1223021/full
_version_ 1797767055490940928
author Lieve Verlinden
Stefanie Doms
Iris Janssens
Mark B. Meyer
J. Wesley Pike
Geert Carmeliet
Annemieke Verstuyf
author_facet Lieve Verlinden
Stefanie Doms
Iris Janssens
Mark B. Meyer
J. Wesley Pike
Geert Carmeliet
Annemieke Verstuyf
author_sort Lieve Verlinden
collection DOAJ
description IntroductionNeuropilin 2 (NRP2) mediates the effects of class 3 semaphorins and vascular endothelial growth factor and is implicated in axonal guidance and angiogenesis. Moreover, NRP2 expression is suggested to be involved in the regulation of bone homeostasis. Indeed, osteoblasts and osteoclasts express NRP2 and male and female global Nrp2 knockout mice have a reduced bone mass accompanied by reduced osteoblast and increased osteoclast counts.MethodsWe first examined the in vitro effect of the calciotropic hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on Nrp2 transcription in osteoblasts. We next generated mice with a conditional deletion of Nrp2 in the osteoblast cell lineage under control of the paired related homeobox 1 promoter and mice with a conditional Nrp2 knockdown in osteoclasts under control of the Lysozyme promoter. Mice were examined under basal conditions or after treatment with either the bone anabolic vitamin D3 analog WY 1048 or with 1,25(OH)2D3.Results and discussionWe show that Nrp2 expression is induced by 1,25(OH)2D3 in osteoblasts and is associated with enrichment of the vitamin D receptor in an intronic region of the Nrp2 gene. In male mice, conditional deletion of Nrp2 in osteoblast precursors and mature osteoblasts recapitulated the bone phenotype of global Nrp2 knockout mice, with a reduced cortical cross-sectional tissue area and lower trabecular bone content. However, female mice with reduced osteoblastic Nrp2 expression display a reduced cross-sectional tissue area but have a normal trabecular bone mass. Treatment with the vitamin D3 analog WY 1048 (0.4 μg/kg/d, 14 days, ip) resulted in a similar increase in bone mass in both genotypes and genders. Deleting Nrp2 from the osteoclast lineage did not result in a bone phenotype, even though in vitro osteoclastogenesis of hematopoietic cells derived from mutant mice was significantly increased. Moreover, treatment with a high dose of 1,25(OH)2D3 (0.5 μg/kg/d, 6 days, ip), to induce osteoclast-mediated bone resorption, resulted in a similar reduction in trabecular and cortical bone mass. In conclusion, osteoblastic Nrp2 expression is suggested to regulate bone homeostasis in a sex-specific manner.
first_indexed 2024-03-12T20:33:44Z
format Article
id doaj.art-ebe7e524e4a4478983c68aea0c4b42f5
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-12T20:33:44Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-ebe7e524e4a4478983c68aea0c4b42f52023-08-01T17:35:50ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-08-011410.3389/fendo.2023.12230211223021Neuropilin 2 in osteoblasts regulates trabecular bone mass in male miceLieve Verlinden0Stefanie Doms1Iris Janssens2Mark B. Meyer3J. Wesley Pike4Geert Carmeliet5Annemieke Verstuyf6Department of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, BelgiumDepartment of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, BelgiumDepartment of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, BelgiumDepartment of Nutritional Sciences, University of Wisconsin-Madision, Madison, WI, United StatesDepartment of Biochemistry, University of Wisconsin-Madision, Madison, WI, United StatesDepartment of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, BelgiumDepartment of Chronic Diseases and Metabolism, Clinical and Experimental Endocrinology, KU Leuven, Leuven, BelgiumIntroductionNeuropilin 2 (NRP2) mediates the effects of class 3 semaphorins and vascular endothelial growth factor and is implicated in axonal guidance and angiogenesis. Moreover, NRP2 expression is suggested to be involved in the regulation of bone homeostasis. Indeed, osteoblasts and osteoclasts express NRP2 and male and female global Nrp2 knockout mice have a reduced bone mass accompanied by reduced osteoblast and increased osteoclast counts.MethodsWe first examined the in vitro effect of the calciotropic hormone 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on Nrp2 transcription in osteoblasts. We next generated mice with a conditional deletion of Nrp2 in the osteoblast cell lineage under control of the paired related homeobox 1 promoter and mice with a conditional Nrp2 knockdown in osteoclasts under control of the Lysozyme promoter. Mice were examined under basal conditions or after treatment with either the bone anabolic vitamin D3 analog WY 1048 or with 1,25(OH)2D3.Results and discussionWe show that Nrp2 expression is induced by 1,25(OH)2D3 in osteoblasts and is associated with enrichment of the vitamin D receptor in an intronic region of the Nrp2 gene. In male mice, conditional deletion of Nrp2 in osteoblast precursors and mature osteoblasts recapitulated the bone phenotype of global Nrp2 knockout mice, with a reduced cortical cross-sectional tissue area and lower trabecular bone content. However, female mice with reduced osteoblastic Nrp2 expression display a reduced cross-sectional tissue area but have a normal trabecular bone mass. Treatment with the vitamin D3 analog WY 1048 (0.4 μg/kg/d, 14 days, ip) resulted in a similar increase in bone mass in both genotypes and genders. Deleting Nrp2 from the osteoclast lineage did not result in a bone phenotype, even though in vitro osteoclastogenesis of hematopoietic cells derived from mutant mice was significantly increased. Moreover, treatment with a high dose of 1,25(OH)2D3 (0.5 μg/kg/d, 6 days, ip), to induce osteoclast-mediated bone resorption, resulted in a similar reduction in trabecular and cortical bone mass. In conclusion, osteoblastic Nrp2 expression is suggested to regulate bone homeostasis in a sex-specific manner.https://www.frontiersin.org/articles/10.3389/fendo.2023.1223021/fullneuropilin 2bonevitamin Dosteoblastosteoclast
spellingShingle Lieve Verlinden
Stefanie Doms
Iris Janssens
Mark B. Meyer
J. Wesley Pike
Geert Carmeliet
Annemieke Verstuyf
Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
Frontiers in Endocrinology
neuropilin 2
bone
vitamin D
osteoblast
osteoclast
title Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
title_full Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
title_fullStr Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
title_full_unstemmed Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
title_short Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
title_sort neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice
topic neuropilin 2
bone
vitamin D
osteoblast
osteoclast
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1223021/full
work_keys_str_mv AT lieveverlinden neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT stefaniedoms neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT irisjanssens neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT markbmeyer neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT jwesleypike neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT geertcarmeliet neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice
AT annemiekeverstuyf neuropilin2inosteoblastsregulatestrabecularbonemassinmalemice